Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-11-30

Clinical Trial Update: A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease [Phase 3]

View source ↗

Summary

Phase 3 trial comparing moxifloxacin monotherapy vs levofloxacin plus metronidazole for uncomplicated pelvic inflammatory disease; the study has completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levofloxacin (Levofloxacin)
  • METRONIDAZOLE (Metronidazole)
  • Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Bayer | Conditions: Pelvic Inflammatory Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-11-30